35,104,116 On August 22, 2022, Novo Nordisk announced the primary results of the Phase II clinical trial for the dual-action compound CagriSema, which demonstrated effective blood sugar reduction and weight loss
Interactions Semaglutide can interact with certain medications, including: Insulin and sulfonylureas combination use can increase the risk of low blood sugar (hypoglycemia)
Happy Ending I had hoped to be more positive in this article, but I think there are some nutritional issues worth highlighting
Children weighing 65 kg or less can drink up to 3 mL/kg per hour of clear fluids if thirsty, up until the time they're called and taken into the operating theatre
It's important to note that GLP-1 receptor agonists have been associated with rare but serious digestive complications, including pancreatitis and gallbladder disease, which can affect stool appearance
The popularity of GLP-1 drugs as a treatment for obesity meets a sobering reality of poor adherence and high cost of care in the real world, and it may be quite some time before these measures and health metrics improve in any substantial way. The latest report covers several key topics: Primes clinical position